These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29330070)

  • 1. Neutropenia as a Complication of Tumefactive Demyelinating Disease: A Case Report.
    Webb K; Osorio M
    PM R; 2018 Aug; 10(8):877-879. PubMed ID: 29330070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric tumefactive demyelination: case series and review of the literature.
    McAdam LC; Blaser SI; Banwell BL
    Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumefactive demyelination.
    Nadkar MY; Deore RA; Singh R
    J Assoc Physicians India; 2008 Nov; 56():901-3. PubMed ID: 19263691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia.
    Dwivedi RA; Dwivedi RE; Durnian JM; Young CA
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary tumefactive demyelinating lesions in children.
    Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
    J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
    Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
    Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma.
    Van Haver AS; Debruyne F; Sanders K; Verstappen A
    Mult Scler Relat Disord; 2020 Jul; 42():102060. PubMed ID: 32217464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing Tumefactive Demyelination: A Case Report.
    Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
    Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
    Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
    Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent tumefactive demyelination in a child.
    Puri V; Chaudhry N; Gulati P; Tatke M; Singh D
    J Clin Neurosci; 2005 May; 12(4):495-500. PubMed ID: 15925795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
    Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
    J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
    Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
    Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
    Weinshenker BG
    Mult Scler; 2015 Nov; 21(13):1746-7. PubMed ID: 26362899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
    Dastgir J; DiMario FJ
    J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.